Genetic Technologies Ltd has released a press release.
Market update on sales, early test results and launch of CIT
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- USA Form F3 Registration Statement Lodged with SEC
- Receipt of Delisting Notification Letter from Nasdaq
- Half Yearly Report and Accounts
- Breast Cancer Test US Sales Update
- Updated Form F-1 Prospectus SEC Filing
Later from Genetic Technologies
- US$1.8 Million Capital Raising
- US$1.44 Million capital raising
- Genetic Technologies Announces USD 8 Million capital raising
- US Prospectus Lodgement
- US Patent Office Grants Key Risk Test Patent
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies